Radionuclide-based pharmaceuticals enhance imaging strategies in breast cancer, suggesting better clinical relevance and diagnostic performance.
Multi-target imaging strategies may better address intra- and inter-lesional heterogeneity. Larger prospective cohorts are needed to define diagnostic performance, clinical relevance and theranostic value in BC.
No takes yet. Share an insight, caveat, or question.
Paraiso et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: